The Enterprise Value as of November 2024 (TTM) for Rallybio Corporation (RLYB) is 25.72M

According to Rallybio Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 25.72M. This represents a change of -64.35% compared to the average of 72.13M of the last 4 quarters.

Rallybio Corporation (RLYB) Historical Enterprise Value (quarterly & annually)

How has RLYB Enterprise Value performed in the past?

The mean historical Enterprise Value of Rallybio Corporation over the last ten years is 220.56M. The current 25.72M Enterprise Value has changed 1.07% with respect to the historical average. Over the past ten years (40 quarters), RLYB's Enterprise Value was at its highest in in the March 2020 quarter at 333.11M. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Rallybio Corporation (RLYB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Rallybio Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Rallybio Corporation (RLYB) Average Enterprise Value

How has RLYB Enterprise Value performed in the past?

The current Enterprise Value of Rallybio Corporation (RLYB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Rallybio Corporation (RLYB) Enterprise Value vs. Peers

How is RLYB’s Enterprise Value compared to its peers?

Rallybio Corporation’s Enterprise Value is less than Century Therapeutics, Inc. (122.51M), less than Edgewise Therapeutics, Inc. (3.20B), less than C4 Therapeutics, Inc. (465.92M), less than Mineralys Therapeutics, Inc. (603.45M), less than Cullinan Oncology, Inc. (812.44M), less than Molecular Partners AG (57.61M), greater than AN2 Therapeutics, Inc. (5.46M), less than Pharvaris N.V. (837.65M), less than PepGen Inc. (174.94M), less than PMV Pharmaceuticals, Inc. (48.39M), less than Opthea Limited (656.58M), less than Third Harmonic Bio, Inc. (249.86M), less than Monte Rosa Therapeutics, Inc. (480.81M), less than Eliem Therapeutics, Inc. (119.64M), less than MediciNova, Inc. (38.55M),

Build a custom stock screener for Rallybio Corporation (RLYB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rallybio Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rallybio Corporation (RLYB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rallybio Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.